DrugPatentWatch Database Preview
Hikma Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for HIKMA, and when can generic versions of HIKMA drugs launch?
HIKMA has three hundred and thirty-five approved drugs.
There are five US patents protecting HIKMA drugs. There are two tentative approvals on HIKMA drugs.
Summary for Hikma
| US Patents: | 5 |
| Tradenames: | 234 |
| Ingredients: | 215 |
| NDAs: | 335 |
| Patent Litigation for Hikma: | See patent lawsuits for Hikma |
| PTAB Cases with Hikma as petitioner: | See PTAB cases with Hikma as petitioner |
Drugs and US Patents for Hikma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | CEVIMELINE HYDROCHLORIDE | cevimeline hydrochloride | CAPSULE;ORAL | 091591-001 | Jul 8, 2013 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hikma | THIOTHIXENE HYDROCHLORIDE INTENSOL | thiothixene hydrochloride | CONCENTRATE;ORAL | 073494-001 | Jun 30, 1992 | DISCN | No | No | Start Trial | Start Trial | |||||
| Hikma | INFUMORPH | morphine sulfate | INJECTABLE;INJECTION | 018565-003 | Jul 19, 1991 | AP | RX | Yes | Yes | Start Trial | Start Trial | ||||
| Hikma | CIPROFLOXACIN HYDROCHLORIDE | ciprofloxacin hydrochloride | TABLET;ORAL | 076558-004 | Jun 9, 2004 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hikma Pharms | SERTRALINE HYDROCHLORIDE | sertraline hydrochloride | TABLET;ORAL | 077864-003 | Aug 10, 2009 | DISCN | No | No | Start Trial | Start Trial | |||||
| Hikma Intl Pharms | AMINOPHYLLINE | aminophylline | TABLET;ORAL | 084540-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Hikma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Hikma | ATIVAN | lorazepam | INJECTABLE;INJECTION | 018140-001 | Approved Prior to Jan 1, 1982 | 4,017,616 | Start Trial |
| Hikma | ATIVAN | lorazepam | INJECTABLE;INJECTION | 018140-002 | Approved Prior to Jan 1, 1982 | 4,017,616 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for HIKMA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 1 mg | ➤ Subscribe | 2009-08-14 |
| ➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
| ➤ Subscribe | Capsules | 0.6 mg | ➤ Subscribe | 2016-06-10 |
| ➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
